Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor
- 30 April 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 106 (8) , 1413-1424
Abstract
Rationale : Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2. However, the underlying mechanism by which a single mutation in such a large molecule produces drastic effects on channel function remains unresolved. Objective : Using a knock-in (KI) mouse model with a human CPVT-associated RyR2 mutation (R2474S), we investigated the molecular mechanism by which CPVT is induced by a single point mutation within the RyR2. Methods and Results : The R2474S/+ KI mice showed no apparent structural or histological abnormalities in the heart, but they showed clear indications of other abnormalities. Bidirectional or polymorphic ventricular tachycardia was induced after exercise on a treadmill. The interaction between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains of the RyR2 (an intrinsic mechanism to close Ca 2+ channels) was weakened (domain unzipping). On protein kinase A-mediated phosphorylation of the RyR2, this domain unzipping further increased, resulting in a significant increase in the frequency of spontaneous Ca 2+ transients. cAMP-induced aberrant Ca 2+ release events (Ca 2+ sparks/waves) occurred at much lower sarcoplasmic reticulum Ca 2+ content as compared to the wild type. Addition of a domain-unzipping peptide, DPc10 (amino acids 2460 to 2495), to the wild type reproduced the aforementioned abnormalities that are characteristic of the R2474S/+ KI mice. Addition of DPc10 to the (cAMP-treated) KI cardiomyocytes produced no further effect. Conclusions : A single point mutation within the RyR2 sensitizes the channel to agonists and reduces the threshold of luminal [Ca 2+ ] for activation, primarily mediated by defective interdomain interaction within the RyR2.Keywords
This publication has 23 references indexed in Scilit:
- Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine ReceptorJACC, 2009
- Increased Ca 2+ Sensitivity of the Ryanodine Receptor Mutant RyR2 R4496C Underlies Catecholaminergic Polymorphic Ventricular TachycardiaCirculation Research, 2009
- Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytesBiochemical and Biophysical Research Communications, 2008
- Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in miceJournal of Clinical Investigation, 2008
- Three-Dimensional Localization of Serine 2808, a Phosphorylation Site in Cardiac Ryanodine ReceptorJournal of Biological Chemistry, 2007
- Localization of an NH2-terminal Disease-causing Mutation Hot Spot to the “Clamp” Region in the Three-dimensional Structure of the Cardiac Ryanodine ReceptorJournal of Biological Chemistry, 2007
- Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathyProceedings of the National Academy of Sciences, 2006
- Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation Research, 2006
- Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmiaNature Clinical Practice Cardiovascular Medicine, 2006
- Spectroscopic Monitoring of Local Conformational Changes during the Intramolecular Domain−Domain Interaction of the Ryanodine ReceptorBiochemistry, 2002